| |
Chiesi CAREDIRECT (Bethkis, Pertzye)
|
Chiesi CareDirect Patient Assistance Program
PO Box 30317
Bethesda, MD 20824
Phone
:
888-865-1222
Fax:
866-410-6241
|
|
Eligibility
|
| > |
This program is intended for patients that are uninsured or are underinsured with no prescription coverage and are a US citizen or legal entrant. Medicare Part D patients are not eligible for this program. Must provide diagnosis code. Income must be at or below 400% of FPL. |
| Who Can Apply
|
| > |
Doctors and Patients can call to request an application via fax, email or download one from the website. The application may be returned via fax or mail. |
|
Required
|
| > |
Doctors and patients must complete and sign the application. Patient must attach proof of income and other requested documentation. Patient and Doctor are notified within 1-2 business days. |
|
Supply
|
| > |
Amount supplied as prescribed by Doctor |
|
Ship To
|
| > |
Medication is shipped to Patient's home. Refills are automatically sent out and the Patient must submit a new application every 12 months. |
|
Note
|
| > |
This program was formerly known as Cornerstone CAREDIRECT.
The program also includes copay assistance and a nutritional rebate program. The nutritional rebate program is for Pertzye patients only. |
| |
Includes Support for This Drug
NOTE: Linked drugs are available for Prescribers to Apply Online now.
Click drug logo or drug name to start online application.
|
| Bethkis solution; inhalation |
| Pertzye capsule; delayed release |
| |
Printable Application Forms
Applications that patients can fill out and bring to their doctor.
|
| Download printable Form Chiesi CareDirect PAP |
(Requires Acrobat Reader) 
|
| |
|
|
| |
Zyflo Connect Patient Assistance Program
|
,
Phone
:
844-699-9356
Fax:
|
|
Eligibility
|
| > |
Uninsured or Underinsured with no prescription coverage. Medicare part D eligibility is determined case by case. Income requirements for this program have not been disclosed. Patient must be a US citizen or legal entrant. |
| Who Can Apply
|
| > |
Doctor/Doctor's office must call to request application, which will be sent to the Doctor's office and must be faxed back from the Doctor's office. No online application available. |
|
Required
|
| > |
Doctor must complete section and sign. Patient must complete section, sign, attach proof of income and other requested documentation. Patient and Doctor will be notified of acceptance. |
|
Supply
|
| > |
Amount/supply not specified. |
|
Ship To
|
| > |
Medication will be shipped to Patient's home in 1-2 business days. Refills are automatically sent out and patient must complete a new application every 12 months. |
|
Note
|
| > |
Resources for HEALTHCARE PROFESSIONALS ONLY.
Physician must call to obtain an enrollment form. |
| |
Includes Support for This Drug
NOTE: Linked drugs are available for Prescribers to Apply Online now.
Click drug logo or drug name to start online application.
|
| Zyflo CR tablet; extended release |
| |
| |
|
|
| |
Zyflo Connect Co-Pay Program
|
,
Phone
:
844-699-9356
Fax:
|
|
Eligibility
|
| > |
This program is intended for patients that are uninsured or are underinsured. Medicare Part D patients are not eligible for this program. Patients must be a US resident or resident of Puerto Rico. Income requirements for this program have not been disclosed. |
| Who Can Apply
|
| > |
Patient must call to enroll once Doctor gives them the prescription. No online application available. |
|
Required
|
| > |
|
|
Supply
|
| > |
30 day supply. Refill limit, refill process and re-application not specified. |
|
Ship To
|
| > |
Medication will be sent to Patient's home. |
|
Note
|
| > |
Out-of-pocket benefit equals an amount up to $2,500 per month with a maximum benefit of $30,000 per year. If a patient exceeds the maximum monthly benefit of $2,500, the patient will be responsible for the outstanding balance.
This program expires December 31, 2016 |
| |
Includes Support for This Drug
NOTE: Linked drugs are available for Prescribers to Apply Online now.
Click drug logo or drug name to start online application.
|
| Zyflo CR tablet; extended release |
| |
| |
|
|